Technology

Tenax Therapeutics

$2.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.75%) Today
+$0.09 (+3.36%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TENX and other stocks, options, and ETFs commission-free!

About TENX

Tenax Therapeutics, Inc. Common Stock, also called Tenax Therapeutics, is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. The listed name for TENX is Tenax Therapeutics, Inc. Common Stock.

CEO
Anthony A. DiTonno
Employees
9
Headquarters
Morrisville, North Carolina
Founded
1967
Market Cap
43.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.67M
High Today
$3.68
Low Today
$2.38
Open Price
$2.46
Volume
12.43M
52 Week High
$3.68
52 Week Low
$0.25

Collections

TENX Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 29, Pre-Market

You May Also Like

FCRD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure